Carlos A. Sariol to Dengue
This is a "connection" page, showing publications Carlos A. Sariol has written about Dengue.
Connection Strength
3.708
-
Serrano-Collazo C, P?rez-Guzm?n EX, Pantoja P, Hassert MA, Rodr?guez IV, Giavedoni L, Hodara V, Parodi L, Cruz L, Arana T, Mart?nez MI, White L, Brien JD, de Silva A, Pinto AK, Sariol CA. Effective control of early Zika virus replication by Dengue immunity is associated to the length of time between the 2 infections but not mediated by antibodies. PLoS Negl Trop Dis. 2020 05; 14(5):e0008285.
Score: 0.677
-
P?rez-Guzm?n EX, Pantoja P, Serrano-Collazo C, Hassert MA, Ortiz-Rosa A, Rodr?guez IV, Giavedoni L, Hodara V, Parodi L, Cruz L, Arana T, White LJ, Mart?nez MI, Weiskopf D, Brien JD, de Silva A, Pinto AK, Sariol CA. Time elapsed between Zika and dengue virus infections affects antibody and T cell responses. Nat Commun. 2019 09 20; 10(1):4316.
Score: 0.646
-
Pantoja P, P?rez-Guzm?n EX, Rodr?guez IV, White LJ, Gonz?lez O, Serrano C, Giavedoni L, Hodara V, Cruz L, Arana T, Mart?nez MI, Hassert MA, Brien JD, Pinto AK, de Silva A, Sariol CA. Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus. Nat Commun. 2017 06 23; 8:15674.
Score: 0.553
-
Sariol CA, Mart?nez MI, Rivera F, Rodr?guez IV, Pantoja P, Abel K, Arana T, Giavedoni L, Hodara V, White LJ, Angler? YI, Montaner LJ, Kraiselburd EN. Decreased dengue replication and an increased anti-viral humoral response with the use of combined Toll-like receptor 3 and 7/8 agonists in macaques. PLoS One. 2011 Apr 29; 6(4):e19323.
Score: 0.361
-
Sariol CA, Mu?oz-Jord?n JL, Abel K, Rosado LC, Pantoja P, Giavedoni L, Rodriguez IV, White LJ, Mart?nez M, Arana T, Kraiselburd EN. Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1. Clin Vaccine Immunol. 2007 Jun; 14(6):756-66.
Score: 0.272
-
Young E, Yount B, Pantoja P, Henein S, Meganck RM, McBride J, Munt JE, Baric TJ, Zhu D, Scobey T, Dong S, Tse LV, Martinez MI, Burgos AG, Graham RL, White L, DeSilva A, Sariol CA, Baric RS. A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity. Nat Commun. 2023 03 13; 14(1):1371.
Score: 0.205
-
Chen RE, Smith BK, Errico JM, Gordon DN, Winkler ES, VanBlargan LA, Desai C, Handley SA, Dowd KA, Amaro-Carambot E, Cardosa MJ, Sariol CA, Kallas EG, S?kaly RP, Vasilakis N, Fremont DH, Whitehead SS, Pierson TC, Diamond MS. Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity. Cell Host Microbe. 2021 11 10; 29(11):1634-1648.e5.
Score: 0.186
-
Sariol CA, Pelegrino JL, Martinez A, Arteaga E, Kouri G, Guzman MG. Detection and genetic relationship of dengue virus sequences in seventeen-year-old paraffin-embedded samples from Cuba. Am J Trop Med Hyg. 1999 Dec; 61(6):994-1000.
Score: 0.164
-
Stauft CB, Song Y, Gorbatsevych O, Pantoja P, Rodriguez IV, Futcher B, Sariol CA, Wimmer E. Extensive genomic recoding by codon-pair deoptimization selective for mammals is a flexible tool to generate attenuated vaccine candidates for dengue virus 2. Virology. 2019 11; 537:237-245.
Score: 0.161
-
Sariol CA, Nogueira ML, Vasilakis N. A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease? Trends Microbiol. 2018 03; 26(3):186-190.
Score: 0.142
-
Sirivichayakul C, Barranco-Santana EA, Esquilin-Rivera I, Oh HM, Raanan M, Sariol CA, Shek LP, Simasathien S, Smith MK, Velez ID, Wallace D, Gordon GS, Stinchcomb DT. Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study. J Infect Dis. 2016 May 15; 213(10):1562-72.
Score: 0.125
-
Messer WB, de Alwis R, Yount BL, Royal SR, Huynh JP, Smith SA, Crowe JE, Doranz BJ, Kahle KM, Pfaff JM, White LJ, Sariol CA, de Silva AM, Baric RS. Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity. Proc Natl Acad Sci U S A. 2014 Feb 04; 111(5):1939-44.
Score: 0.109
-
White LJ, Sariol CA, Mattocks MD, Wahala M P B W, Yingsiwaphat V, Collier ML, Whitley J, Mikkelsen R, Rodriguez IV, Martinez MI, de Silva A, Johnston RE. An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection. J Virol. 2013 Mar; 87(6):3409-24.
Score: 0.101
-
Alvarez M, Guzm?n MG, Rosario D, V?zquez S, Pelegrino JL, Sariol CA, Kour? G. [Direct sequencing of an amplified product from a serum sample]. Rev Cubana Med Trop. 1996; 48(1):53-5.
Score: 0.008